Eascra Biotech
Pre-clinicalEascra Biotech is a nanomedicine company that provides precision therapeutic delivery for hard-to-penetrate tissues like articular cartilage, kidneys, and ECM-rich solid tumors. Our groundbreaking, proprietary Janus base nanoparticles (JBNps) are a DNA-inspired synthetic molecule (non-lipid) that fully encapsulates a cargo rendering it room temperature stable while maintaining bioactivity for extended periods. JBNps can deliver a variety of therapeutic cargoes including siRNA, mRNA, cas 9, pr...
Private Company
Total funding raised: $3.5M
About
Eascra Biotech is a nanomedicine company that provides precision therapeutic delivery for hard-to-penetrate tissues like articular cartilage, kidneys, and ECM-rich solid tumors. Our groundbreaking, proprietary Janus base nanoparticles (JBNps) are a DNA-inspired synthetic molecule (non-lipid) that fully encapsulates a cargo rendering it room temperature stable while maintaining bioactivity for extended periods. JBNps can deliver a variety of therapeutic cargoes including siRNA, mRNA, cas 9, pr...